June 7, 2022 — Stereotaxis, a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...
June 7, 2022 — Visura Technologies, Inc., a privately-held medical device company dedicated to delivering state-of-the ...
June 7, 2022 — ScImage Inc., a leading provider of enterprise imaging solutions and DiA Imaging Analysis, a global ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 3, 3033 — Esperion announced findings from a real-world analysis of more than 400,000 patients at high-risk for ...
June 3, 2022 — Texas Children's Hospital patient Garrett Richardson, 21, is alive today because his quick-thinking ...
June 2, 2022 — Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, announced print ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 2, 2022 — With over 30 years' experience in vascular assessment, Huntleigh, a member of the Arjo family, has ...
June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the ...
Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of May ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 1, 2022 — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced that its ...
June 1, 2022 — Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease ...
June 1, 2022 — Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to ...
May 31, 2022 — Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and ...
May 31, 2022 — Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure ...